Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Dementia in People with Type 2 Diabetes-A Population-Based Cohort Study

被引：0
|
作者：
Tang, Huilin
Shaaban, C. Elizabeth
Wu, Yonghui
Magoc, Tanja
Donahoo, William T.
Dekosky, Steven T.
Bian, Jiang
Guo, Jingchuan
机构：
来源：
DIABETES | 2023年 / 72卷
关键词：
D O I：
10.2337/db23-894-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
894-P
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Sodium-glucose cotransporter 2 inhibitors and risk of fractures in postmenopausal women with type 2 diabetes: A nationwide cohort study
    Ko, Hwa Yeon
    Bea, Sungho
    Jeong, Han Eol
    Park, Sohee
    Shin, Ju-Young
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 81 - 82
  • [22] Use of sodium-glucose cotransporter-2 inhibitors and risk of acute kidney injury in older adults with diabetes: a population-based cohort study
    Iskander, Carina
    Cherney, David Z.
    Clemens, Kristin K.
    Dixon, Stephanie N.
    Harel, Ziv
    Jeyakumar, Nivethika
    McArthur, Eric
    Muanda, Flory Tsobo
    Parikh, Chirag R.
    Paterson, J. Michael
    Tangri, Navdeep
    Udell, Jacob A.
    Wald, Ron
    Garg, Amit X.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2020, 192 (14) : E351 - E360
  • [23] Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Retinopathy in Patients With Type 2 Diabetes
    Yen, Fu-Shun
    Wei, James Cheng-Chung
    Yu, Teng-Shun
    Hung, Yu-Tung
    Hsu, Chih-Cheng
    Hwu, Chii-Min
    JAMA NETWORK OPEN, 2023, 6 (12) : E2348431
  • [24] Sodium-Glucose Cotransporter 2 Inhibitors and Nephrolithiasis Risk in Patients With Type 2 Diabetes
    Paik, Julie M.
    Tesfaye, Helen
    Curhan, Gary C.
    Zakoul, Heidi
    Wexler, Deborah J.
    Patorno, Elisabetta
    JAMA INTERNAL MEDICINE, 2024, 184 (03) : 265 - 274
  • [25] Sodium-glucose cotransporter-2 inhibitors and clinical outcomes in patients with hypertrophic cardiomyopathy and diabetes: A population-based cohort study
    Jung, Mi-Hyang
    Cho, Jung Sun
    Lee, So-Young
    Youn, Jong-Chan
    Choi, Young
    Chung, Woo-Baek
    Lee, Jungkuk
    Kang, Dongwoo
    Kwon, Woojin
    Kim, Tae-Seok
    Ihm, Sang-Hyun
    Jung, Hae Ok
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2024,
  • [26] Sodium-glucose cotransporter 2 inhibitors for the management of type 2 diabetes
    Siamashvili, Maka
    Davis, Stephen N.
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (16) : 2181 - 2198
  • [27] INITIATION OF SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS AND RECURRENT GOUT FLARES IN GOUT PATIENTS WITH TYPE 2 DIABETES: A GENERAL POPULATION-BASED COHORT STUDY
    Mccormick, N.
    Yokose, C.
    Wei, J.
    Lu, L.
    Wexler, D.
    Avina-Zubieta, J. A.
    De Vera, M.
    Zhang, Y.
    Choi, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 103 - 104
  • [28] Patterns and Patients' Characteristics Associated With Use of Sodium-Glucose Cotransporter-2 Inhibitors Among Adults With Type 2 Diabetes: A Population-based Cohort Study
    Campbell, Dennis B.
    Campbell, David J. T.
    Au, Flora
    Beall, Reed F.
    Ronksley, Paul E.
    Chew, Derek S.
    Ogundeji, Yewande
    Manns, Braden J.
    Hemmelgarn, Brenda R.
    Tonelli, Marcello
    Quinn, Amity E.
    CANADIAN JOURNAL OF DIABETES, 2023, 47 (01) : 58 - +
  • [29] Cumulative sodium-glucose cotransporter 2 inhibitor exposure and incident dementia: A population-based cohort analysis
    Wu, Che-Yuan
    Iskander, Carina
    Wang, Christa
    Xiong, Lisa Y.
    Shah, Baiju R.
    Edwards, Jodi D.
    Kapral, Moira K.
    Herrmann, Nathan
    Lanctot, Krista L.
    Cogo-Moreira, Hugo
    MacIntosh, Bradley J.
    Rabin, Jennifer S.
    Black, Sandra E.
    Saskin, Refik
    Swardfager, Walter
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 28 - 28
  • [30] Sodium-glucose cotransporter-2 inhibitors use and risk of dementia in different ethnoracial groups with type 2 diabetes
    Yang, Shih-Chi
    Liao, Wen-Chieh
    Jhang, Yi-Sheng
    Chang, Hui-Chin
    Su, Yu-Jung
    Chen, Shiu-Jau
    Gau, Shuo-Yan
    ALZHEIMERS & DEMENTIA, 2025, 21 (01)
12345